An Ethical Imperative to Ensure Uninterrupted HIV Care Following Therapeutic Trials: One Experience in Peru

AIDS Patient Care STDS. 2022 Jun;36(6):205-207. doi: 10.1089/apc.2022.0075.

Authors

Katherine Garcia-Rosales¹, Karin Sosa Barbaran², Jessica Rios², Delia Pinto-Santini¹, Maria Del Rosario Leon², Jorge A Gallardo-Cartagena^{3

4}, John MacRae², Mey Leon², Javier Valencia-Huamaní², Esmelda Montalban², Pedro Gonzales², Ann Duerr^{1

5}, Javier R Lama^{2

5}, Rachel Bender Ignacio^{1

5}

Affiliations

¹ Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
² Asociacion Civil Impacta Salud y Educacion, Lima, Peru.
³ Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Lima, Peru.
⁴ Universidad Nacional Mayor de San Marcos, Lima, Peru.
⁵ Department of Medicine (RBI), Global Health (AD, JRL), and Epidemiology (RBI and AD), University of Washington, Seattle, Washington, USA.

No abstract available

Publication types

Letter

MeSH terms

HIV Infections* / drug therapy
HIV Infections* / epidemiology
Humans
Peru / epidemiology

Grants and funding